Ampoules & syringes are highly critical in the treatment of different conditions and diseases. For example, an ampoule can be used to inject a patient with medicine that is injected directly into their veins so that the medication can reach where it's needed. In addition to using an ampoule to administer medicine, it can also be used to inject various items into one another. For example, an ampoule can be used to inject gels and other similar products inside a syringe, which is great for filling cavities or crevices in one's mouth or around the nose. They can be made from a wide variety of different materials, including silicone, plastic, foam, glass, and more.
Growing prevalence of chronic disease is fostering growth of the ampoules & syringes market. According to the National Health Council, chronic diseases affect around 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions.
Additionally, increasing partnership and collaboration among key players in the market is expected to provide lucrative growth opportunities over the forecast period. For instance, in May 2018, In April 2021, West Pharmaceutical Services (West), provider of injectable drug administration, has announced its partnership with Venus Remedies for prefilled ISO standard 1mL long staked-needle syringes.
- This report provides in-depth analysis of the ampoules & syringes market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global ampoules & syringes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Schott AG, Gerresheimer AG, Becton, Dickinson, and Company, West Pharmaceutical Services, Inc., Nipro Corporation, Vetter Pharma International GmbH, Stevanato Group, TOPAS Advanced Polymers, JSR CORPORATION., Baxter International Inc., Terumo Corporation, B. Braun Melsungen AG, Unilife Corporation, Ypsomed Holding AG, Medtronic, and Zeon Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global ampoules & syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ampoules & syringes market
-
-
-
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Others
-
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
-
- Schott AG
- Gerresheimer AG
- Becton, Dickinson, and Company
- West Pharmaceutical Services, Inc.
- Nipro Corporation
- Vetter Pharma International GmbH
- Stevanato Group
- TOPAS Advanced Polymers
- JSR CORPORATION
- Baxter International Inc.
- Terumo Corporation
- Braun Melsungen AG
- Unilife Corporation
- Ypsomed Holding AG
- Medtronic
- Zeon Corporation
